Pediatric Arthritis Study | Juvenile Idiopathic Arthritis Study FAQ
16682
page-template,page-template-full_width,page-template-full_width-php,page,page-id-16682,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-9.4.1,wpb-js-composer js-comp-ver-4.12,vc_responsive

Juvenile Idiopathic Arthritis Study FAQ

How do I know if my child or adolescent qualifies for this clinical study?

If your child or adolescent is 2 to 17 years old and has JIA symptoms, they may be able to participate. Both males and females can participate. Your child’s doctor will be able to determine their eligibility.

How long will my child be enrolled in this study?

If your child is eligible and enrolls in this clinical study, their participation will last approximately 44 weeks. Participants may stop participation in the study at any time. If your child participates, s/he may be eligible to enroll in a long-term maintenance extension study with the same investigational medication.

How is the investigational medication administered?

In this clinical study, the investigational medication will be available as a pill and a liquid taken orally (by mouth) twice a day.

Why is this investigational medication being studied for this condition?

The investigational medication is being developed to treat the symptoms of JIA.

Will it cost anything to participate?

No, all study medication and study-related medical care will be provided at no cost to you while your child is enrolled in the study. Qualified children and their parents/guardians may also be reimbursed for study related expenses.

Do you have a brochure?

For your convenience, a downloadable brochure is provided for you and your family to review and discuss the clinical trial further. Click the button below to download.

Additional Questions?

For additional questions, please reach out to one of our study sites found on our location map.

If your child or someone you care for are between the age of 2 to 17 and have JIA, please consider participating in this research study.